HopeStage
Back to all studies
CompletedNCT00179062

Risperidone compared with olanzapine for weight and health outcomes in mental health care

About this title

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Read the official source — NCT00179062
Medication studyAges 18–60United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
NashvilleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2000
Recruitment status
Completed
Enrollment listed in the registry
300
Sponsor
Vanderbilt University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT00179062
Official title
Show the full official title

Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Nashville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Vanderbilt University, a university.

Did this study involve medication?

Yes. The study involved medication, including olanzapine versus risperidone.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies